ArticlePlants (Basel, Switzerland)2025
Sparse-MoE-SAM: A Lightweight Framework Integrating MoE and SAM with a Sparse Attention Mechanism for Plant Disease Segmentation in Resource-Constrained Environments.
Article in Plants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in Artificial Intelligence for Plant Research.Plants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plant disease segmentation has achieved significant progress with the help of artificial intelligence. However, deploying high-accuracy segmentation models in resource-limited settings faces three key challenges, as follows: (A) Traditional dense attention mechanisms incur quadratic computational complexity growth (O(n2d)), rendering them ill-suited for low-power hardware. (B) Naturally sparse spatial distributions and large-scale variations in the lesions on leaves necessitate models that concurrently capture long-range dependencies and local details. (C) Complex backgrounds and variable lighting in field images often induce segmentation errors. To address these challenges, we propose Sparse-MoE-SAM, an efficient framework based on an enhanced Segment Anything Model (SAM). This deep learning framework integrates sparse attention mechanisms with a two-stage mixture of experts (MoE) decoder. The sparse attention dynamically activates key channels aligned with lesion sparsity patterns, reducing self-attention complexity while preserving long-range context. Stage 1 of the MoE decoder performs coarse-grained boundary localization; Stage 2 achieves fine-grained segmentation by leveraging specialized experts within the MoE, significantly enhancing edge discrimination accuracy. The expert repository-comprising standard convolutions, dilated convolutions, and depthwise separable convolutions-dynamically routes features through optimized processing paths based on input texture and lesion morphology. This enables robust segmentation across diverse leaf textures and plant developmental stages. Further, we design a sparse attention-enhanced Atrous Spatial Pyramid Pooling (ASPP) module to capture multi-scale contexts for both extensive lesions and small spots. Evaluations on three heterogeneous datasets (PlantVillage Extended, CVPPP, and our self-collected field images) show that Sparse-MoE-SAM achieves a mean Intersection-over-Union (mIoU) of 94.2%-surpassing standard SAM by 2.5 percentage points-while reducing computational costs by 23.7% compared to the original SAM baseline. The model also demonstrates balanced performance across disease classes and enhanced hardware compatibility. Our work validates that integrating sparse attention with MoE mechanisms sustains accuracy while drastically lowering computational demands, enabling the scalable deployment of plant disease segmentation models on mobile and edge devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.